МANOMETRY IN THE MANAGEMENT OF PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE

Gastroesophageal reflux disease (GERD) is a widespread disease that has a significant impact on the quality of life of patients and is a leading risk factor for the development of esophageal adenocarcinoma. Currently, proton pump inhibitor therapy (PPI) is the basic treatment for patients with GERD, but 1/3 of patients show resistance to the prescribed therapy.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-12-27
DOI
https://doi.org/10.5281/zenodo.14560700
Primary Topic
Gastroesophageal reflux and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

МANOMETRY IN THE MANAGEMENT OF PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE

Zenodo (CERN European Organization for Nuclear Research)
Gastroesophageal reflux and treatments
article

МANOMETRY IN THE MANAGEMENT OF PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE

article en

Abstract

Gastroesophageal reflux disease (GERD) is a widespread disease that has a significant impact on the quality of life of patients and is a leading risk factor for the development of esophageal adenocarcinoma. Currently, proton pump inhibitor therapy (PPI) is the basic treatment for patients with GERD, but 1/3 of patients show resistance to the prescribed therapy.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 47%
Gastroesophageal reflux and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

МANOMETRY IN THE MANAGEMENT OF PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS